ReviewOncoTargets and therapy2016

Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned.

Javier Pinilla-Ibarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.